Analytics

How to interpret an HPLC chromatogram

6 min read Last updated March 10, 2026By PrimeGen Research TeamAdvanced

A practical reading guide for the chromatogram attached to a certificate of analysis: what retention time does and does not tell you, how integration and baseline placement change the reported figure, and which peak shapes indicate which impurity classes.

In summary

A practical reading guide for the chromatogram attached to a certificate of analysis: what retention time does and does not tell you, how integration and baseline placement change the reported figure, and which peak shapes indicate which impurity classes. This guide is published by PrimeGen Co., a United States supplier of lyophilized research peptides, and covers analytics for laboratory research contexts only.

Topic:
Analytics
Reading time:
9 min read
Sections:
What a chromatogram actually records · Retention time identifies nothing on its own · Reading peak shape · Integration and baseline placement · What to check before trusting a trace · Peak shape as evidence · Baseline, gradient and integration choices
Last updated:
March 10, 2026
Published by:
PrimeGen Co. research library
Scope:
Laboratory research use only — not medical guidance

Key takeaways

  • Retention time identifies nothing on its own; it is only meaningful against a reference run on the same method.
  • Shoulders and unresolved humps next to the main peak usually indicate closely related deletion or oxidised species.
  • Integration settings and baseline placement can move a reported purity figure by several tenths of a percent.

What a chromatogram actually records

A reversed-phase HPLC trace plots detector response — almost always UV absorbance at 214 or 220 nanometres, where the peptide bond itself absorbs — against elution time. Sample is injected onto a hydrophobic stationary phase and washed off with an increasing gradient of organic solvent. Compounds leave the column in order of hydrophobicity, and each produces a peak.

Purity is calculated from areas, not heights: the target peak area divided by the total integrated area of all peaks, expressed as a percentage. That definition carries two consequences. Anything that does not absorb at the detection wavelength is invisible to the calculation, and anything excluded from integration — for example a solvent front cut off at the start of the run — does not count against the result.

Retention time identifies nothing on its own

Retention time is a property of the method, not of the molecule. Change the gradient slope, the column chemistry, the column dimensions, the temperature or the flow rate and the same peptide elutes somewhere else. A retention time is only informative when compared against a reference standard run under identical conditions on the same instrument.

This is the single most common misreading of a certificate. A stated retention time confirms that the laboratory ran a method; it does not confirm identity. Identity comes from mass spectrometry, which is why a complete release package always pairs the two.

Reading peak shape

A well-behaved peak is narrow and close to symmetrical. Departures from that shape are diagnostic. A shoulder on the leading or trailing edge usually indicates a closely related species — most often a deletion sequence differing by one residue, or a diastereomer formed by racemisation during coupling. A broad, low, poorly resolved peak in a long or hydrophobic sequence commonly reflects on-column aggregation or conformational exchange rather than chemical impurity.

Tailing across all peaks, including any system peaks, points to a column or instrument issue rather than to the sample. Fronting typically indicates column overload — too much material injected — which also compresses apparent resolution and can inflate the reported purity by hiding small neighbours under a distorted main peak.

Small satellite peaks eluting just before the target are frequently more polar oxidation products; a peak sixteen daltons heavier on the corresponding mass spectrum confirms methionine oxidation. Late-eluting minor peaks are usually more hydrophobic adducts, often incompletely scavenged protecting-group fragments from cleavage.

Integration and baseline placement

Every reported purity figure embeds analyst or software decisions about where each peak begins and ends and where the baseline lies. Drawing the baseline across a rising background rather than under it, or setting a rejection threshold that discards small peaks, will shift a result by several tenths of a percent. None of this is misconduct — it is the ordinary discretion built into chromatographic integration — but it does mean purity figures should be read as measurements with a method-dependent uncertainty, not as exact constants.

In practice this makes within-laboratory, within-method comparisons far more meaningful than cross-vendor ones. Two laboratories reporting 98.6 and 99.1 percent for equivalent material are not necessarily disagreeing about the material.

What to check before trusting a trace

Confirm the sample identifier and lot number printed on the chromatogram match the vial and the certificate header. Check the method block states column, mobile phases, gradient, flow rate, wavelength and injection volume. Verify the run time is long enough that the gradient reached its end — a trace that stops early can leave late-eluting hydrophobic impurities uncounted. Look for a stable baseline before and after the peak of interest.

Finally, check the trace is an instrument output rather than a redrawn image. Genuine chromatograms carry axis labels, timestamps, integration marks and a peak table with retention times and area percentages. A smooth, unlabelled curve in a marketing PDF is an illustration, not analytical evidence.

Peak shape as evidence

A symmetrical, narrow main peak is the expected result and the baseline against which anything else is read. Tailing — a peak with an extended rear edge — usually indicates secondary interactions with residual silanols on the stationary phase or column overload, and it degrades the resolution between the main peak and closely eluting impurities. Fronting more often indicates overload or a solvent-strength mismatch in the injection.

Peak width carries information about the separation rather than the sample. Broadening across a run suggests column deterioration; a single broad peak among sharp ones can indicate conformational exchange on the timescale of the separation, which some cyclic and proline-containing sequences show routinely.

Shoulders are the finding that most often changes an interpretation. A shoulder is a partially resolved second species; because integration software may or may not split it, a purity figure computed over a shouldered peak can overstate purity substantially. This is precisely why the chromatogram itself, and not only the summary table, belongs in a release package.

Baseline, gradient and integration choices

Baseline drift is normal in gradient reversed-phase runs because the mobile phase composition — and therefore its UV absorbance — changes throughout. What matters is whether the drift is smooth and whether the integration baseline has been drawn sensibly beneath the peaks. An aggressive baseline can absorb small early-eluting impurities into the noise.

The gradient determines what can be resolved at all. A steep gradient runs quickly and co-elutes close relatives; a shallow gradient resolves them and takes longer. A purity figure from a fifteen-minute steep method is not comparable to one from a shallow forty-minute method on the same sample, and the difference can be several percentage points.

Integration parameters complete the picture: which peaks were included, whether the void volume was excluded, and what threshold was applied to reject noise. Two analysts can integrate one chromatogram to different purity values without either being wrong, which is why method transparency is part of what makes a certificate credible.

Frequently asked questions

Can I compare purity figures from two different laboratories?
Only approximately. Detection wavelength, gradient, column chemistry, injection load and integration settings all influence the number. Differences of a few tenths of a percent between laboratories are usually methodological rather than material. Comparisons within one laboratory and one method are far more reliable.
Does a shoulder on the main peak mean the material is bad?
It means a closely related species is present and only partially resolved — commonly a deletion sequence or a diastereomer. Whether that matters depends on the study. The important point is that the certificate's purity figure already accounts for it if the integration captured it correctly.
Why is 214 nm used instead of 280 nm?
The peptide bond absorbs strongly near 214 nm, so every peptide is detectable regardless of sequence. Absorbance at 280 nm depends on aromatic residues — tryptophan, tyrosine and to a lesser extent phenylalanine — so peptides lacking them would be effectively invisible at that wavelength.
What does a shoulder on the main peak mean?
It is a partially resolved second species. Depending on how the integration is drawn, it may be counted within the main peak, which inflates the reported purity — one of the main reasons to review the chromatogram rather than only the summary figure.
Why does the baseline rise during a run?
Gradient reversed-phase methods change mobile phase composition over the run, and the changing organic content alters UV absorbance. Smooth drift is expected; irregular steps or noise are not.

Related research compounds

Compounds covered by this article, each with its own monograph, specifications and lot-specific certificate of analysis.

Related certificates of analysis

Independent, lot-specific analysis for the compounds covered above. Every report is indexed in the certificate library.

About the author

PrimeGen Research Team

Analytical & technical writing, PrimeGen Co.

Our library is written in-house by the same team that reviews incoming lot analytics, reads third-party certificates of analysis and maintains compound documentation. Articles are educational reference material for laboratory professionals and describe published in vitro and preclinical literature only.

Published September 17, 2025 · Last reviewed March 10, 2026

References and further reading

  1. Reversed-phase HPLC of peptides: method development and interpretationPubMed, U.S. National Library of Medicine
  2. Chromatography general chapter and system suitabilityUnited States Pharmacopeia
  3. PubChem compound and substance databaseNational Center for Biotechnology Information

Cite this resource

This page is editorial reference material published by PrimeGen Co.. It is not a peer-reviewed publication and carries no DOI; cite it as a web resource.

Title
How to interpret an HPLC chromatogram
Publisher
PrimeGen Co.
Last updated
March 10, 2026
PrimeGen Co.. "How to interpret an HPLC chromatogram." PrimeGen Co. research documentation. Last updated March 10, 2026. https://primegenco.com/library/interpreting-hplc-chromatograms

Where this fits in the Knowledge Center

Each hub sequences the guides, quality documentation and bench notes for a single topic, so you can move from this page into a structured reading path rather than a flat index.

Research use only

For laboratory research purposes only. Not intended for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Purchasers are responsible for complying with all applicable laws and regulations.

Explore further

Move from this article into the catalog, the analytical documentation behind each lot, and the policies that govern every order.